University of Vermont

UVM ScholarWorks
University Libraries Faculty and Staff
Publications

University Libraries

3-12-2020

Barriers and Facilitators to Use of a Clinical Evidence Technology
in the Management of Skin Problems in Primary Care: Insights
from Mixed Methods
Marianne D. Burke Ph.D.
The University of Vermont, mburke@uvm.edu

Liliane Savard DPT
The University of Vermont, liliane.savard@uvm.edu

Alan Rubin MD
The University of Vermont, Alan.Rubin@med.uvm.edu

Benjamin Littenberg MD
The University of Vermont, Benjamin.Littenberg@med.uvm.edu

Follow this and additional works at: https://scholarworks.uvm.edu/libfacpub
Part of the Analytical, Diagnostic and Therapeutic Techniques and Equipment Commons, Health
Information Technology Commons, Health Sciences and Medical Librarianship Commons, Medical
Education Commons, and the Skin and Connective Tissue Diseases Commons

Recommended Citation
Burke MD, Savard LB, Rubin AS, Littenberg B. Barriers and facilitators to use of a clinical evidence
technology in the management of skin problems in primary care: insights from mixed methods. J Med
Libr Assoc. 2020;108(3):428-439. doi:10.5195/jmla.2020.787

This Article is brought to you for free and open access by the University Libraries at UVM ScholarWorks. It has been
accepted for inclusion in University Libraries Faculty and Staff Publications by an authorized administrator of UVM
ScholarWorks. For more information, please contact scholarworks@uvm.edu.

Barriers and Facilitators to Use of a Clinical Evidence Technology in the Management of
Skin Problems in Primary Care: Insights from Mixed Methods
ABSTRACT
Objective: Few studies have examined the impact of a single clinical evidence technology
(CET) on provider practice or patient outcomes from the provider’s perspective. A previous
cluster-randomized controlled trial with patient-reported data tested the effectiveness of a CET
(i.e., VisualDx) in improving skin problem outcomes but found no significant effect. The
objectives of this follow-up study were to identify barriers and facilitators to the use of the CET
from the perspective of primary care providers (PCPs) and to identify reasons why the CET did
not affect outcomes in the trial.
Methods: Using a convergent mixed methods design, PCPs completed a post-trial survey and
participated in interviews about using the CET for the management of patients’ skin problems.
Data from both methods were integrated.
Results: PCPs found the CET somewhat easy to use but only occasionally useful. Less
experienced PCPs used the CET more frequently. Data from interviews revealed barriers and
facilitators at four steps of evidence-based practice: clinical question recognition, information
acquisition, appraisal of relevance, and application with patients. Facilitators included
uncertainty in dermatology, intention for use, convenience of access, diagnosis and treatment
support, and patient communication. Barriers included confidence in dermatology, preference for
other sources, interface difficulties, presence of irrelevant information, and lack of decision
impact.
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Conclusion: PCPs found the CET useful for diagnosis, treatment support, and patient
communication. However, the barriers of interface difficulties, irrelevant search results, and
preferred use of other sources limited its positive impact on patient skin problem management.
Keywords entered in JMLA:
Evidence-Based Medicine; Evidence-Based Practice; Decision-Support Systems; Medical
Informatics Applications; Libraries, Hospital; Information Storage and Retrieval; Databases,
Factual; Information-Seeking Behavior; Skin Diseases; Primary Health Care; Technology
Assessment; Mixed Methods
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INTRODUCTION
Clinical evidence technologies (CETs) are information sources derived from medical research
literature that assist health care providers in continued learning, decision-making, and patient
care. Evidence-based medicine (EBM), defined as “the integration of best research evidence with
clinical expertise and patient values” [1], endorses the use of research-based evidence found in
CETs, including medical journals, databases, clinical guidelines, and synthesized clinical
summaries, to find evidence for patient care. Clinicians report referencing CETs and using the
information therein to make better diagnosis and treatment decisions [2-4]. However, they also
report barriers to answering their clinical questions, such as poor technology access, lack of
relevant evidence sources, and time constraints [5-7].
Dermatology is an area of concern in primary care for which previous literature
extensively discusses the goals of improving diagnostic accuracy, improving the management of
skin disease, and reducing referrals [8-12]. Some studies in primary care and hospital settings
show that a dermatology education toolkit [13] and diagnostic support CET [14] can improve
provider confidence and diagnostic accuracy. However, few studies have examined the impact of
a single CET on provider practice or patient outcomes from the provider’s perspective. The
present study followed up on a previous cluster-randomized controlled trial to understand why
and how primary care providers (PCPs) use a CET, VisualDx, to care for skin disease patients
[15]. VisualDx, a factual knowledge database and diagnostic tool, matches patient symptoms
with images to suggest likely diagnoses and management strategies [16]. In the original trial, 32
PCPs were randomly assigned to use or not use VisualDx, and over 400 of their patients with
skin complaints were interviewed about the outcomes of their primary care visit. PCP
participation in the original trial averaged six months. Study results showed that VisualDx use
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did not have a significant effect on the resolution of symptoms or the number of return
appointments.
The objectives of this follow-up investigation were two-fold: (1) to identify barriers and
facilitators to PCPs’ use of the CET in a patient care context and (2) to gain insight from PCP
reports into why CET use did not affect patient-level outcomes.
METHODS
We used a convergent, mixed methods design [17] in which we combined a quantitative survey
with qualitative interviews to realize a more complete understanding of PCP experiences using
the CET in a complex patient care setting. The methods had equal priority and were conducted
concurrently in February and March of 2018, 19-20 months after PCPs’ participation in the
original trial had concluded.
We followed the guidelines of O’Cathain et al. for the reporting of mixed methods to enhance
the clarity of the methodology and analysis presentation [18]. The University of Vermont
Institutional Review Board approved the original clinical trial, including baseline and postsurveys of PCPs in May 2015 and the qualitative interview investigation in January 2018.
Participants included faculty and residents in family medicine and internal medicine
primary care clinics who participated in the original trial. All PCPs in the original trial were
invited to participate in the closed-answer post-trial survey, which was administered online or inperson (Appendix A). Data were entered and stored in REDCap [19]. Demographic data,
including years in practice, resident vs. attending status, family medicine vs. internal medicine
status, and gender, were collected in the baseline survey of the original trial. Questions in the
post-trial survey varied by participant arm. All PCPs were queried on their use of VisualDx
during and after the trial and their use of other information sources after the trial. PCPs in the
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CET arm were also asked about the number of times used, ease of use, and usefulness of
VisualDx. The survey instrument design was informed by the technology acceptance model,
which posits that intention, perceived ease of use, and perceived usefulness are important factors
for acceptance and continued use of technologies introduced in the workplace [20]. Survey data
were analyzed with descriptive statistics in Stata version 14.2 [21].
PCPs in the CET arm also participated in a semi-structured interview conducted inperson and digitally recorded by the principal investigator (PI) (Appendix B). Interviews were
transcribed by the PI and a research assistant. We chose a behavioral steps model based on the
EBM paradigm to inform the semi-structured interview instrument design and frame the analysis
of qualitative data (Figure 1). The EBM paradigm includes sequential behavioral steps taken by
clinicians to find and apply the best available evidence. These steps, as described in EBM
textbooks [1, 22] and reaffirmed by expert teaching and clinician panels [23], are: (1) ask clinical
questions when uncertainty arises, (2) acquire the best available evidence, (3) appraise and
interpret the evidence found, and (4) apply evidence considering patient values and preferences
[22, 23]. The PI conducted initial coding of PCP statements using NVivo version 12 qualitative
analysis software [24]. The PI and two independent team members then refined codes and
identified emergent themes. Final themes were decided by team consensus. We organized themes
as barriers or facilitators and noted when PCPs referenced the themes at each behavioral step.
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Figure 1: Behavioral steps model based on the EBM paradigm.

To integrate the quantitative and qualitative results, we compared survey results on ease
of use and usefulness to interview themes using the triangulation protocol described by
O’Cathain et al. [25], which utilizes concepts of convergence, complementarity, dissonance, and
silence to compare findings between methods in mixed methods studies.
RESULTS
Quantitative Survey Results
Twenty-one of the 32 (66%) PCPs in the original trial participated in the post-trial survey: 13 of
17 (76%) in the CET arm, and 8 of 15 (53%) in the control arm (Table 1).
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Table 1: Characteristics of PCPs and CET usage in post-trial survey
n
Gender (Men), n (%)
Resident (vs. Attending), n (%)
Family Med (vs. Internal Med), n (%)
PCP Education
Physician, n (%)
Advanced Practice Nurse, n (%)
Years in Practice
Median
Range
Followed VisualDx Usage Protocol in
the Trial, n (%)
Times used VisualDx During the Trial
Median
Range
Used VisualDx After the Trial (yes), n
(%)

All
21
10 (47%)
4 (10%)
10 (47%)

CET
13
6 (46%)
4 (31%)
5 (38%)

Control
8
4 (50%)
0
5 (63%)

20 (95%)
1 (5%)

13 (100%)
0

7 (88%)
1 (12%)

17
1-40
20 (95%)

12
1-40
13 (100%)

18
2-39
7 (88%)

14 (67%)

10
3-125
9 (70%)

----5 (63%)

Protocol Fidelity and Frequency
PCPs in the CET arm used VisualDx during the trial, whereas PCPs in the control arm, with one
exception, did not, indicating protocol fidelity in both arms. PCPs in the CET arm used VisualDx
a median of 10 times in the 6-month average trial participation period. Nearly half of CET arm
PCPs (46%) reported using VisualDx with most of their patients with skin problems.
Ease of Use and Usefulness
Of the CET arm PCPs, ten (77%) described VisualDx as “somewhat easy” or “very easy” to use,
whereas three (23%) found it “somewhat difficult” or “difficult” to use. When asked how useful
VisualDx was for diagnosing and treating patients, five PCPs (38%) responded “usually”, five
(38%) responded occasionally, and three (23%) responded “not at all”; none found it “always”
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useful. These findings indicate that the CET was perceived as more easy to use than actually
useful (Table 2).
Years in Practice
Compared with more experienced PCPs, PCPs with 5 or fewer years in practice used the CET
more often (median 10 vs. 15 times) and were more likely to use the CET with more than half of
their patients (67% vs. 29%). All (100%) of less experienced PCPs found the CET very or
somewhat easy to use (100%) compared with 57% of more experienced PCPs (Table 2).
Table 2: CET frequency of use, ease of use, and usefulness depending on years in practice
All CET
Practice Years
Practice Years
users
≤5
>5
N
13
6
7
VisualDx Use during the trial,
10 (3-125)
15 (5-30)
10 (3-125)
median uses (range)
Used VisualDx with >50% of skin
6 (46)
4 (67)
2 (29)
patients, n (%)
Ease of use, n (%)
Very or somewhat difficult
3 (23)
0 (0)
3 (43)
Very or somewhat easy
10 (77)
6 (100)
4 (57)
Usefulness, n (%)
Not at all or occasionally useful
8 (62)
3 (50)
5 (71)
Usually or always useful
5 (38)
3 (50)
2 (29)
Usage of VisualDx and Other CETs Post-Trial
Two-thirds (67%) of PCPs used VisualDx after the trial, and all (100%) used other information
sources for the care of patients with skin problems. In a typical month post-trial, six PCPs (29%)
reported using VisualDx, eleven (52%) used UpToDate, six used textbooks, four used Google,
one used Epocrates, and one used DynaMed. None used PubMed/MEDLINE, other citation
databases, or journal articles.
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Qualitative Interview Results
Eleven CET arm PCPs participated in an interview, including three residents and eight attending
physicians who had been in practice for 1-40 years. We organized PCP interview statements into
facilitator and barrier themes and noted the behavioral step context of the statement. Facilitator
themes included intention to use the CET, uncertainty in dermatology, electronic health record
(EHR) access, diagnosis/treatment support, and patient communication. Barrier themes included
confidence in dermatology, time pressure, interface difficulties, use of other preferred sources,
irrelevant information, and lack of impact on patient care. Below, we present facilitators and
barriers to use of the CET at each behavioral step of the EBM model, with representative PCP
statements presented in Table 3.
Step 1: Ask a Clinical Question
Facilitators to using the CET at this step were uncertainty in dermatology and intention to use the
CET with skin problem patients. Some PCPs recognized uncertainty in dermatology, especially
the diagnosis of rashes, as an area of concern due to less training and fewer rigorous approaches
than in other domains. Several residents stated that because of such uncertainty, evidence-based
information resources in dermatology were especially needed. One resident expressed her
intention to use the CET from the beginning and estimated that she used it with nearly all her
patients with skin problems.
Barriers to using the CET at this step were confidence in dermatology, use of other
preferred sources, and time pressure. PCPs who expressed confidence felt less need for
information-seeking. Some had taken additional course work in dermatology, which increased
their confidence and reduced their CET use. Use of other evidence sources instead of VisualDx
also deterred CET use. Some did not always choose VisualDx as their first or only source despite
9

the trial protocol. Instead, PCPs felt that colleagues and other CETs, such as print textbooks,
UpToDate, drug databases, and Internet images, would be better at times. Furthermore,
perceived lack of time in a patient encounter prevented PCPs from seeking answers from any
information source, even when they recognized uncertainty. Instead, they sometimes used a “try
this and see if it works” approach.
Step 2: Acquire Evidence
Facilitators to using the CET at this step were access to the CET through the EHR and perceived
overall ease of use of the CET. The EHR was almost always the only means by which PCPs
accessed VisualDx, as it was convenient to access quickly from the desktop computers in patient
exam rooms. Although the CET mobile version was available on smart phones and tablets, PCPs
did not use it for patient care. Several stated they found the VisualDx interface easy to learn and
use, though there was a “small learning curve”.
Despite its overall ease of use, the main barrier to CET use at this step was interface
difficulties. About half of PCPs found the CET’s interactive diagnosis tool confusing, “not user
friendly”, and unpredictable. Some lacked confidence in their ability to use the CET effectively
even though they viewed a training tutorial as part of their enrollment in the trial. One PCP
reported loss of access through the EHR after 1 month in the trial and did not return to using the
resource even though she received assistance from a technical help desk.
Step 3: Appraise Evidence for Quality and Relevance
Facilitators to using the CET at this step were the availability of good quality evidence,
assistance in patient diagnosis, and treatment decision support. PCPs appraised VisualDx
information as good and reliable because it was validated by expert dermatologists. They knew it
was more reliable than images on Internet search engines, to which “anybody…can upload a
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picture”. None described seeking higher levels of evidence, such as diagnostic tools evaluated in
randomized trials usually found in the journal literature. The CET’s relevance to diagnosis
emerged in support of differential diagnosis expansion and confirmation of diagnosis. Residents
found the CET’s interactive diagnostic tool particularly relevant when they had little idea of the
diagnosis and needed to broaden the differential. Experienced physicians more often wanted to
confirm a diagnosis, which VisualDx supported at times. With confirmation, PCPs were more
likely to treat the problem themselves and avoid a referral. There were also situations in which
diagnosis confirmation prompted a referral. Furthermore, new treatments described in the CET
affected some PCPs’ treatment decisions and served to update their usual practice.
Barriers to using the CET at this step included the presence of irrelevant information.
PCPs often retrieved too much information, requiring time-consuming information-sifting or a
new search. Experienced clinicians, in particular, felt that the range of diagnoses and images
retrieved was excessively broad, making it difficult to narrow the differential or confirm the most
likely diagnosis. In addition, PCPs considered the CET as one information source among others
to assist with the management of skin conditions, even though other sources are not optimized
for this topic. VisualDx was used as “just one tool” among others or a corroborator of evidence
found in another source.
Step 4: Apply Evidence to and with Patient
Facilitators to using the CET at this step were patient communication and shared decisions. PCPs
found VisualDx images and information applicable for patient education and building rapport.
The images helped them show patients how their condition had improved, which enhanced
agreement on treatments and patient confidence. A few PCPs found the dermatology images too
graphic to show patients but did share the information found. Some shared a full range of
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VisualDx information with patients, including alternative diagnoses and multiple images, in a
shared decision-making process.
The main barrier to using the CET at this step was a lack of evidence found that applied
to a particular patient. Despite positive examples of communication with patients, many PCPs
did not recall any real impact of using the CET with patients. That is, the information retrieved
was relevant in a general way but did not aid in making decisions or offering a “different path
forward” from what the PCP would have done anyway.

Table 3: Representative PCP statements related to facilitators and barriers to CET use
aligned with behavioral EBM steps
Step 1: Ask a Theme
Provider Statements
clinical
question
Facilitators
Intention to use “I think I used it close to every time I saw a skin problem,
CET
unless it was super obvious…But even then, I would use it to
get treatment recommendations.” PCP08 (Resident, 3 years)

Uncertainty in
dermatology

“When I had a patient that had a skin complaint, I was
supposed to open VisualDx… I tried to be pretty diligent about
it.” PCP01 (Resident, 1 year)
“[Dermatology] is way harder because we just don’t have the
exposure. … So, I think something like VisualDx is totally
necessary.” PCP07 (Resident, 3 years)
“There are certain areas, [like dermatology] where internists in
particular, don't have as much training and we tend to fall
into…less rigorous ways of approaching a diagnosis.” PCP10
(Attending, 22 years)

Barriers

Confidence in
dermatology

“If it's a simple thing that … you feel like you know what it is
and how to treat it, then you obviously wouldn’t use the
resource in that situation.” PCP02 (Attending, 32 years)

“There were a lot of patients where I felt comfortable with
what the problem was.” PCP11 (Attending, 24 years)
Other preferred “I was working…next to a skilled, older practitioner. So often
information
times my first recourse would be going to him.” PCP09
sources
(Attending, 4 years)
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“I used UpToDate quite frequently. And I used Micromedex
quite frequently…I don’t think my use of VisualDx changed
my rates of use of those other resources.” PCP08 (Resident, 3
years)
“I have a favorite dermatology book that I use like I would use
VisualDx.” PCP10 (Attending, 22 years)

Time pressure

Step 2:
Acquire
evidence
Facilitators

EHR access

CET interface
Barrier

CET interface

“Sometimes I just used Google Images” PCP09 (Attending, 4
years)
“When you are already 45 minutes behind schedule and
someone comes in with an [odd] rash, “It’s easy to say, I think
it’s this, try it, if it doesn’t work call me back”.” PCP10
(Attending, 22 years)

“If I’m seeing patients, I’m already in the EMR, and VisualDx
is there. It’s easy to find. 99% of the time that’s what I’d do.”
PCP11 (Attending, 24 years)
“Once I knew what I was doing it, it wasn’t hard to use.”
PCP06 (Attending, 4 years)
“I remember staring at it saying, “Where do I put the
information in?” So, it wasn’t as user friendly for data input”
PCP10 (Attending, 22 years)
“I'm not sure if I’m just not putting in enough [information]”
PCP09 (Attending, 4 years)

Step 3:
Appraise
evidence for
quality and
relevance
Facilitators

Quality of
evidence

Diagnosis
support

“I had a lot of confidence that the material was accurate and
properly edited or authenticated by experts in the field…”
PCP03 (Attending, 34 years)
“The problem with Google Images is [that] anybody…can
upload a picture and tag it with a diagnosis.” PCP10
(Attending, 22 years)
“I did, on a few occasions have no idea what I was looking at
in a patient, and used [VisualDx]…to figure it out.” PCP08
(Resident, 3 years)
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“I can definitely say it helped me feel more confident about a
diagnosis.” PCP02 (Attending, 32 years)
“I did, on a few occasions, have no idea what I was looking at
in the patient and used it to try to figure it out.” PCP08
(Resident, 3 years)

Treatment
support

Barriers

Presence of
irrelevant
information

“…I would often look at a skin lesion or rash and have an
idea…and then …VisualDx would broaden my differential and
sometimes completely change my initial opinion.” PCP07
(Resident, 3 years)
“A lady came in with something strange on her eyes …. Based
on using VisualDx I came up with something I hadn’t
considered. That did prompt a referral to dermatology.” PCP01
(Resident, 1 year)
“I think it changed my rate of dermatology referrals because I
willing to diagnose skin conditions with…more confidence
and to act on those diagnoses.” PCP08 (Resident, 3 years)
“Just as frequently as I found that it was helpful, I found that it
was not helpful at all…I mostly got a lot of extraneous
information and things that…weren't appropriate for what I
was looking for…So some of that time using it was wasted.”
PCP08 (Resident, 3 years)
“If you put basal cell carcinoma in VisualDx, it’s a thousand
pictures of every possible way it can show up. It’s not showing
the typical ones.” PCP03 (Attending, 34 years)

“I remember getting more hits back…a lot more diagnoses than I was expecting -- some of which didn't even look close to
what I described.” PCP10 (Attending, 22 years)
Other preferred “If I knew what the [diagnosis] was but didn’t know how to
information
manage it, I might use UpToDate [more].” PCP11 (Attending,
sources
24 years)
“…If I thought of something, I’d look it up on UpToDate
[also] and see if the pictures and descriptions matched
[VisualDx]” PCP06 (Attending, 4 years)
Step 4: Apply
to and with
patient
Facilitators

Patient
“I used it with patients, especially if they had something that
communication went away; then they could say, “Oh, it did look like that”.”
PCP04 (Attending, 17 years)
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“Helpful for patient communication? Absolutely.” PCP04
(Attending, 17 years)

Shared
decisionmaking

Barrier

No impact on
patient care

“…If you can use a visual to show somebody and say, "Oh this
looks like really what you have," they gain a little bit more
confidence.” PCP09 (Attending, 4 years)
“I would open it up in the patient room oftentimes, and go
through it [all] with them.” PCP06 (Attending, 4 years)
“I would look at VisualDx and it would give me additional
ideas. So, then I would talk to the patient more, come up with a
diagnosis…” PCP08 (Resident, 3 years)
“I can't think of a particular instance where it clinched it for
me or made a clinical decision distinction or difference. It was
more of a tool that I used to augment whatever I was looking
into.” PCP09 (Attending, 4 years)
“Care difference? I would have to say no, that it didn't really
offer me a different path forward.” PCP03 (Attending, 34
years)
“… If I was going to refer to dermatology, I [would] refer to
dermatology. [VisualDx] wouldn't change my mind.” PCP04
(Attending, 17 years)

Mixed Methods Results Integration
When combined, the quantitative survey and qualitative interview results provide a more
complete picture of how PCPs sought and used VisualDx and other information sources to
manage skin problems in patients. The interviews provided context related to each behavioral
step of EBM for the survey responses pertaining to frequency of use, ease of use, and usefulness
for patient care and identified specific barriers and facilitators to CET use. When we compared
four survey variables (usage of the CET, ease of use, usefulness, and use of other information
sources) with the interview themes and sub-themes at the behavioral steps, most comparisons
reflected complementarity, such that the interview statements did not contradict but rather
expanded upon the survey responses (Table 4).
15
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Table 4: Integration of mixed methods
Behavioral step

Survey Results

Triangulation

Step 1: Ask a
clinical question

PCPs used the
CET a median of
10 times; less
experienced PCPs
used the CET a
median of 15
times.
46% of PCPs used
the CET with most
patients.

Complementarity

77% of PCPs
found the CET
somewhat or very
easy to use.

Convergence

No data on CET
interface or EHR
aspects.

Partial Silence

No data on
evidence quality.

Silence

Step 2: Acquire
evidence

Step 3: Appraise
evidence for quality
and relevance

Complementarity

62% of PCPs
Complementarity
reported that the
CET was not
useful or
occasionally useful
for diagnosis and
treatment, whereas

Interview Results:
Barriers (B) and
Facilitators (F)
PCPs expressed
intention and
frequent usage (F)

Experienced PCPs
who expressed
confidence in
dermatology also
expressed a lack of
need and lower
usage (B), whereas
uncertainty signaled
more need and
usage (F).
All but one PCP
found CET access
through the EHR to
be easy (F). The
CET interface was
easy to use for about
half of PCPs (F).
About half of PCPs
reported that the
interactive diagnosis
tool was difficult
and unpredictable at
times (B).
PCPs expressed that
the quality of
evidence in the CET
was satisfactory (F).
PCPs expressed that
the CET was
relevant and useful
for differential
diagnosis expansion,
diagnosis
confirmation, and
17

38% reported that
it was usually
useful.

67% of PCP used
VisualDx in a
recent month posttrial.

Complementarity

Step 4: Apply
No specific data on Silence
evidence to and with application to
patient
patients.

treatment discovery
(F). Others said it
was “just as often”
irrelevant or
unhelpful (B).
PCPs reported that
other information
sources were as or
more useful than the
CET (B).
PCPs expressed that
the CET facilitated
patient education
and shared decisions
(F) and prompted
and avoided
referrals (F) but had
little application to
specific patient
decisions (B).

DISCUSSION
This study identified facilitators and barriers to effective use of a dermatology-focused CET for
skin problem management in the context of patient care from the perspective of PCPs. It also
identified possible reasons why use of the CET did not impact patient outcomes in the original
trial. The brief closed-answer survey of PCPs provided summary information on the number of
times used, ease of use, and usefulness of the CET. Barriers and facilitators identified in
interviews enriched our understanding of the complex behavioral EBM steps that influence use
of a CET. Integration of the results of mixed methods provided complementary insights.
Barriers and Facilitators to CET Use in Evidence-Based Practice
Multiple barriers to the use of clinical evidence sources by PCPs have been described in the
literature over the last decades. In two studies of PCPs, Ely et al. identified lack of time to seek
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and acquire needed information and lack of skill as barriers [5, 26]. Ely et al. also identified the
retrieval of too much information and the irrelevance of the retrieved information as problems. In
a focus group study of primary care internal medicine residents, poor access to technology and
lack of relevant sources in the practice setting were barriers [7]. These same barriers were also
identified in the present study. In addition, a qualitative study identified the barrier of failure of
the evidence sources to account for patient complexity [27]. A 2012 systematic review including
22 studies published between 1997 and 2010 reported barriers to EBM practice at each
behavioral step that were similar to those reported in previous literature except for a novel barrier
at the Apply Evidence step: patient disagreement with best evidence [28]. An additional barrier
identified in our study was PCP confidence in the dermatology domain.
Cook et al. identified multiple facilitators in a study that identified strengths of
“knowledge resources” (i.e., CETs). Effective sources were found to be efficient, credible,
integrated with the clinical workflow, familiar to the user, optimized for the topic, and supportive
of patient education [29]. In our study, convenient access to VisualDx through the EHR partially
overcame the barrier of time pressure. The ability to include patient factors in the interactive
diagnosis tool partially accounted for relevance to complex patient characteristics. However, the
unpredictability of search results decreased efficiency and reduced the benefit of using VisualDx
as opposed to other familiar sources. Utility for patient communication, education, and shared
decision-making emerged as benefits when evidence was applied with patient preferences and
values, an essential step in evidence-based practice.
Seeking information from multiple sources for the same clinical question is typical
behavior for clinicians [2, 30]. One study noted that 3.5 CET sources were typically referenced
per question [30]. In our study, PCPs preferred multiple CETs if they were convenient. The
19

presence of other sources diluted the impact of VisualDx and reduced the likelihood of detecting
any effects of CET use on patient outcomes in the original trial.
It is possible that evidence-seeking in CETs may be less frequent or more difficult in
dermatology. In a qualitative study of PCP strategies for diagnosing skin problems, preferred
strategies included pattern recognition, “trying out” treatments, and referral to dermatology.
Consulting research-based literature or online sources was seldom used as a strategy [31]. In the
present study, nearly half of PCPs in the CET arm reported using VisualDx with most of their
patients with skin problems, and they frequently used other evidence sources if convenient. This
study did not identify any dermatology evidence source as superior to VisualDx, only that PCPs
used it among other CETs for dermatological problem management.
Our results suggest that VisualDx may be more useful to trainees and new attending
PCPs than those with more experience. Less experienced PCPs seemed to express more ease
using the CET, recognized more uncertainty in dermatology, and expressed need for tools like
VisualDx. For these users, expansion of the differential diagnosis with use of the patient-specific
interactive diagnosis tool facilitated point-of-care learning.
Effect on Patient-level Outcomes
Why did VisualDx use make no difference in the outcomes reported in the original study? It is
possible that the effects were bi-directional. For instance, some PCPs reported that VisualDx use
affected referral patterns. For some, the evidence found for a diagnosis prompted referrals to
dermatology. For others, a referral was avoided, and the clinician gained confidence in treating
the condition. This effect may partially explain why use of the CET did not reduce the overall
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number of patient return appointments (including referrals) for the same skin problem (odds ratio
= 1.26, 95% confidence interval = 0.70 -1.21, p = 0.54) [15].
Likewise, three other intervention studies found that use of a CET did not reduce referrals
to dermatology [13, 32, 33]. While reduction of referrals and other return appointments may be a
clinical goal to save patient and provider time and to reduce costs, its attainment through usage
of CETs has not been established. It is possible that patient communication with use of the CET
could have affected patient satisfaction with care, which could be evaluated in future research.
Implications For Evaluation of CETs
Although this study focused on one CET, the barriers and facilitators to its use may be applicable
in the evaluation of other CETs implemented for point-of-care use. We identified ways that a
single CET may have value for provider management of patient conditions, such as diagnostic
accuracy and identification of best treatments. A CET may also facilitate point-of-care learning
and shared decision-making with patients.
Health sciences librarians directly support the Acquire step in the EBM model by
licensing and providing access to clinical evidence sources. When choosing and licensing CETs,
medical librarians should consider the factors of clinician population, access technology, and
available evidence sources in addition to cost. A CET licensed and implemented for clinical use
should be accessible through the EHR to increase clinician acceptance. Less experienced
clinicians and residents may have different CET use patterns than more experienced PCPs.
Furthermore, use of more than source may be needed to meet clinicians’ clinical evidence needs
for the care of skin problems.
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Limitations
Our study has several limitations that should be considered. It did not include reports from
patients, limiting the interpretations to the perceptions and experience of PCPs. Recall errors
may have affected the reported data, but all PCPs appeared to respond to survey and interview
questions without difficulty. The interviews were conducted by a medical librarian known to
some of the PCPs outside the study, which could have introduced bias. However, all PCPs
agreed to give their true opinions and were assured that their responses would be confidential
and would not affect their access to medical library services. In addition, the study took place in
one academic medical center, limiting its generalizability to other settings.
Conclusion
We identified facilitators and barriers to PCPs’ use of a CET for skin problems in the context of
patient care, which partially explain the results of a previous cluster-randomized controlled trial.
We found that the CET was not consistently useful to PCPs or applicable to patients. However, it
did support some diagnosis and treatment decisions, point-of-care learning, and patient
communication and shared decision-making. These findings could be useful to clinical
administrators and medical librarians considering implementation of CETs to support the
management of dermatological conditions in primary care settings.
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